首页>>Re: Estimated Costs and Long-Term Outcomes of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin in the Veterans Affairs Health System Editorial Comment
Re: Estimated Costs and Long-Term Outcomes of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin in the Veterans Affairs Health System Editorial Comment